Health Care

FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims
FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder
Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder
EXCLUSIVE: Coya Therapeutics Investigational Combination Therapy With GLP-1 Shows Potential For Alzheimer's Disease
EXCLUSIVE: Coya Therapeutics Investigational Combination Therapy With GLP-1 Shows Potential For Alzheimer's Disease

Health Care Recent News

What's Going On With Oscar Health Stock On Tuesday?
What's Going On With Oscar Health Stock On Tuesday?
Oscar Health's $355 million debt offering aims to fuel growth through AI initiatives, cost savings, and expanded healthcare benefits by 2030.
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in high-risk and older adults.
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment
Novo Nordisk plans to seek FDA approval for a high-dose Wegovy, matching Eli Lilly's Zepbound with another weight-loss option for patients.
Endoscopic Clips Redefining GI Care: Market Trends & Future Growth
Endoscopic Clips Redefining GI Care: Market Trends & Future Growth
Oscar Health Stock Is Trending, But Why Is It Down 3% After Hours Today?
Oscar Health Stock Is Trending, But Why Is It Down 3% After Hours Today?
Oscar Health shares dropped 3.63% in after-hours trading, following the announcement of a $350 million convertible notes offering to fund strategic initiatives and reduce costs.
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin
The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data.
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.
Inside Helius Medical's $500 Million Raise — And Its Solana Treasury Plans
Inside Helius Medical's $500 Million Raise — And Its Solana Treasury Plans
As the financial landscape increasingly intertwines with digital assets, companies are exploring innovative ways to integrate cryptocurrency into their business strategies. This shift reflects a broader trend of traditional firms seeking to enhance their financial reserves and capitalize on the burgeoning decentralized finance ecosystem.
Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments
Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments
Monte Rosa's stock jumps as it partners with Novartis to develop degraders for immune diseases, with up to $5.7 billion in payments.
Connect With Us
blueskyinstagramlinkedinyoutube
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved